Australia markets close in 5 hours 30 minutes

Inovio Pharmaceuticals, Inc. (INO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.3600-0.0100 (-0.42%)
At close: 04:00PM EDT
2.3500 -0.01 (-0.42%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 503.89M
Enterprise value 177.14M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)292.33
Price/book (mrq)1.42
Enterprise value/revenue 110.53
Enterprise value/EBITDA -0.55

Trading information

Stock price history

Beta (5Y monthly) 0.88
52-week change 3-75.31%
S&P500 52-week change 3-6.48%
52-week high 39.9600
52-week low 31.3800
50-day moving average 31.8998
200-day moving average 33.8444

Share statistics

Avg vol (3-month) 37.12M
Avg vol (10-day) 35.79M
Shares outstanding 5229.04M
Implied shares outstanding 6N/A
Float 8225.14M
% held by insiders 11.66%
% held by institutions 141.10%
Shares short (14 July 2022) 443.48M
Short ratio (14 July 2022) 46.4
Short % of float (14 July 2022) 419.30%
Short % of shares outstanding (14 July 2022) 418.98%
Shares short (prior month 14 June 2022) 435.91M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:4
Last split date 305 June 2014

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-19,990.89%

Management effectiveness

Return on assets (ttm)-36.40%
Return on equity (ttm)-70.10%

Income statement

Revenue (ttm)1.6M
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)-46.40%
Gross profit (ttm)-247.47M
EBITDA -316.58M
Net income avi to common (ttm)-328.33M
Diluted EPS (ttm)-1.5420
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)360.39M
Total cash per share (mrq)1.57
Total debt (mrq)33.65M
Total debt/equity (mrq)9.48
Current ratio (mrq)6.74
Book value per share (mrq)1.57

Cash flow statement

Operating cash flow (ttm)-224.72M
Levered free cash flow (ttm)-124.95M